JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
URGN Financials - Urogen Pharma Income & Cash Flow | Ledgeburg
URGN - Urogen Pharma Ltd.
USD | NASDAQ | Healthcare
Summary
Summary URGN Stock
Financials
Financials URGN Stock
Loading...
Loading...
Income Statement
Income Statement URGN Stock
Balance Sheet
Balance Sheet URGN Stock
Cash Flow Statement
Cash Flow Statement URGN Stock
Loading...
Loading...
Home
Stocks
Urogen Pharma Ltd. (URGN)
Financials
Financials of URGN
Loading...
Loading...
Loading...
Loading...
Revenue
$109.788M
Operating Income
$-124.863M
Net Income
$-153.494M
Share Count (Basic)
48.116098M
Operating Cash Flow
$-162.444M
Free Cash Flow
$-162.733M
Cash And Short-Term Equivalents
$160.055M
Total Debt
$122.21M
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
FY2021
FY2022
FY2023
Revenue $USD
0
10M
20M
30M
40M
50M
Q1 FY25
Q2 FY25
Q3 FY25
Annual
Quarterly
Net Income $USD
-150M
-140M
-130M
-120M
-110M
-100M
Annual
Quarterly
Margins
Gross
Operating
Net
-200%
-100%
0%
100%
FY2024
FY2025
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-50M
-45M
-40M
-35M
-30M
-25M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-200%
-100%
0%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26